Target intelligence / Profile preview

Pathogenic Expanded CUG Repeat RNA (r(CUG)^exp)

Target
r(CUG)^exp
Molecular classification
Non-coding RNA, mRNA (mutated)
01

Overview

Pathogenic expanded CUG repeat RNAs are structured non-coding regions within certain transcripts that cause disease primarily through toxic gain-of-function at the RNA level. Their unique structure enables them to aberrantly interact with key cellular proteins leading to widespread dysregulation—most prominently seen in myotonic dystrophy type 1—and they represent an important target for therapeutic intervention using structure-specific molecules or nucleic acid-based drugs.

Other names
Expanded CUG repeatsCUG repeat RNAr(CUG)exp tractsMutant DMPK mRNA
02

Mechanism of action

Disrupts protein sequestration; promotes selective degradation/cleavage of mutant transcripts; modifies RNA structure

03

Biological functions

RNA-protein interactionSplicing regulation (disruption)Ribonucleoprotein aggregate formationMitochondrial dysfunction inductionCellular stress induction
04

Disease associations

Myotonic dystrophy type 1 (DM1)Huntington’s disease-like syndromes (some forms)Fragile X-associated tremor/ataxia syndrome (FXTAS - when different triplet repeats occur)
05

Safety considerations

Off-target effects of small moleculesNon-selective ASO bindingImmune response to ASOsDelivery of therapeutics to affected tissuesSpecificity of targeting pathological versus physiological repeats
06

Interacting drugs

Small molecules (CUG-binding)

1 more in the full profile.

07

Biomarkers

r(CUG)^exp levels in patient tissuesMBNL protein sequestration in nuclear fociMis-splicing patterns of target genesExpression levels of cell cycle control genes (e.g., TP53)Senescence mediators (e.g., IGFBP3)Matrix remodeling enzymes (MMPs)Antioxidant response elements (Nrf2 targets)

Beyond the preview

Go deeper on Pathogenic Expanded CUG Repeat RNA (r(CUG)^exp).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic Expanded CUG Repeat RNA (r(CUG)^exp).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call